Assessing the value of atopic dermatitis treatment using Multi-Criteria Decision Analysis (MCDA)
MCDA to create an optimal conceptual framework for evaluating novel treatments in moderate-to-severe AD by establishing the most relevant health outcomes (criteria) for decision-making from all stakeholders’ perspectives (patients, clinicians and payers).